NCT06920719View on ClinicalTrials.gov

Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

June 29, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

July 9, 2025

Conditions

Healthy Subject

Interventions

DRUG

YHP2406

Test drug: YHP2406, Comparator: YHR2501

DRUG

YHR2501

Test drug: YHP2406, Comparator: YHR2501

Trial Locations (1)

08779

H Plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY